The Psychedelic News Feed – Details, episodes & analysis

Podcast details

Technical and general information from the podcast's RSS feed.

The Psychedelic News Feed

Psychedelic Alpha

News

Health & Fitness

Frequency: 1 episode/0d. Total Eps: 1

The Psychedelic News Feed is the audio edition of Psychedelic Alpha's regular news roundup, bringing you a concise update from the worlds of psychedelic drug development, policy, and access. In it, Psychedelic Alpha Editor Josh Hardman provides a brief review of happenings across the field.

Recent rankings

Latest chart positions across Apple Podcasts and Spotify rankings.

Apple Podcasts

Spotify

No recent rankings available

Shared links between episodes and podcasts

Links found in episode descriptions and other podcasts that share them.

See all

https://psychedelicalpha.com
2 shares
https://psychedelicalpha.com/join/
2 shares
https://psychedelicalpha.com/news/no-questions-asked-fdas-psychedelics-public-hearing/
1 share

https://uk.linkedin.com/company/psychedelicalpha
1 share

RSS feed quality and score

Technical evaluation of the podcast's RSS feed quality and structure.

See all

RSS feed quality

To improve

Score global : 52%

Publication history

Monthly episode publishing history over the past years.

Year

Latest published episodes

Recent episodes with titles, durations, and descriptions.

See all

Psychedelics in D.C., FDA’s Framework, and New Zealand’s MDMA Prescribers

Episode 1

Monday, September 21, 2026 • Duration 18:14

In the first episode of The Psychedelic News Feed podcast, Psychedelic Alpha’s editor Josh Hardman runs through a very busy two-week period in the field, including:

Three meetings, or what I’m calling ‘Psychedelics Week’, in D.C.: FDA’s public hearing, an ibogaine-related meeting hosted by ARPA-H, and a congressional briefing
A commentary published by top FDA staff outlining a model for psychedelic drug development
New Zealand’s approval of two psychiatrists to prescribe MDMA
And many other headlines, including: Definium Therapeutics’ Phase 3 LSD for generalised anxiety disorder readout, more data from Compass Pathways’ psilocybin for treatment-resistant depression program, Xylo’s neuroplastogen enters the clinic, Eli Lilly’s acquisition of AtaiBeckley closes, RFK Jr. hosts Bryan Hubbard on his podcast to talk ibogaine, and Usona Institute files a trademark on ‘Arumaya’ a potential brand name for its psilocybin candidate.

The Psychedelic News Feed is published by Psychedelic Alpha and airs every two weeks.

This episode of The Psychedelic News Feed is supported by UBC. As psychedelic therapies move toward potential approvals, UBC helps sponsors navigate the evidence generation, pharmacovigilance, and comprehensive risk management strategies that support a path forward grounded in patient safety. Learn more at ubc.com.

Send us your questions and comments at pod@psychedelicalpha.com

Read more and join our newsletter at https://psychedelicalpha.com

Subscribe to Pα+ for premium insights: https://psychedelicalpha.com/join/

The Psychedelic News Feed – Details, episodes & analysis

Podcast details

Recent rankings

Apple Podcasts

Spotify

Shared links between episodes and podcasts

RSS feed quality and score

Publication history

Latest published episodes

Related Shows Based on Content Similarities

Apple Podcasts

Spotify

Related Shows Based on Content Similarities

The Psychedelic News Feed – Details, episodes & analysis

Podcast details

Recent rankings

Apple Podcasts

Spotify

Shared links between episodes and podcasts

Other9

LinkedIn1

RSS feed quality and score

Publication history

Latest published episodes

Similar podcasts and content

Related Shows Based on Content Similarities

Apple Podcasts

Spotify

Related Shows Based on Content Similarities

Other9

LinkedIn1